tiprankstipranks
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
US Market
AXSM
Axsome Therapeutics
RESEARCH TOOLSreports
Want to see AXSM full AI Analyst Report?

Axsome Therapeutics (AXSM) Income Statement

2,360 Followers

Axsome Therapeutics Income Statement

Last quarter (Q1 2026), Axsome Therapeutics's total revenue was $191.20M, an increase of 57.42% from the same quarter last year. In Q1, Axsome Therapeutics's net income was $-64.54M. See Axsome Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 638.50M$ 385.69M$ 270.60M$ 50.04M$ 0.00
Gross Profit
$ 591.02M$ 352.39M$ 244.53M$ 44.84M$ 0.00
Operating Expenses
$ 760.25M$ 632.95M$ 476.36M$ 224.64M$ 124.71M
Depreciation and Amortization
$ 9.06M$ 7.96M$ 6.83M$ 4.40M$ 76.00K
EBITDA
$ -168.08M$ -272.60M$ -224.99M$ -175.40M$ -124.63M
Operating Income
$ -169.24M$ -280.56M$ -231.82M$ -179.80M$ -124.71M
Other Income/Expenses
$ -14.47M$ -6.57M$ -6.45M$ -7.33M$ -5.70M
Pretax Income
$ -183.70M$ -287.13M$ -238.28M$ -187.13M$ -130.40M
Net Income
$ -183.17M$ -287.22M$ -239.24M$ -187.13M$ -130.40M
Per Share Metrics
Basic EPS
$ -3.68$ -5.99$ -5.27$ -4.60$ -3.47
Diluted EPS
$ -3.68$ -5.99$ -5.27$ -4.60$ -3.47
Weighted Average Shares Outstanding
 49.75M 47.91M 45.43M 40.66M 37.62M
Weighted Average Shares Outstanding (Diluted)
 49.75M 47.91M 45.43M 40.66M 37.62M
Currency in USD

Axsome Therapeutics Earnings and Revenue History